It has been reported that intestine-specific ErbB3 ablation resulted in almost complete absence of intestinal tumors in the ApcMin mouse model of colon cancer and that ErbB3-ErbB4 heterodimers contribute to colon cancer survival [9]. Here, ERBB4 is linked to colonic neoplasm.